Mohamed Imath | Nanotechnology | Excellence in Research

Mr. Mohamed Imath, The Tamil Nadu Dr MGR Medical University, India.

Mohamed Imath is a dedicated research pharmacologist with expertise in oncology, phytochemicals, and nanotechnology. He holds a B. Pharm and M. Pharm in Pharmacology from The Tamil Nadu Dr. MGR Medical University . As a Research Associate at Kairos Kinetic OPC Pvt. Ltd. and Founder & CEO of Healthmeds Generics, he is committed to eco-friendly nanoparticle synthesis, AI-based recombinant vaccine development, and drug research. His work spans in-vitro, in-silico, and in-vivo studies, targeting oral and human pathogens . He has published over 10 Scopus Q1 & Q2 papers, a Lancet Microbe article, and holds a UK design patent.

Publivation Profiles

SCOPUS

Education and Experience

B. Pharm & M. Pharm (Pharmacology) – The Tamil Nadu Dr. MGR Medical University
Diploma in Clinical Research Management (DCRM) – Alchemy Clinical Research Services
Junior Researcher – Saveetha Dental College & Hospitals, Saveetha University (2023-2024)
Research Associate – Kairos Kinetic OPC Pvt. Ltd. (2023–Present)
Founder & CEO, Retail Manager – Healthmeds Generics (2024–Present)

Suitability summary

Mohamed Imath, an accomplished Research Pharmacologist, is honored with the Excellence in Research Award for his pioneering contributions in nanotechnology, pharmacology, and biomedical sciences. His extensive expertise in eco-friendly nanoparticle synthesis, oncology research, and AI-based recombinant vaccine development has significantly advanced the field of pharmaceutical sciences. With numerous publications in Q1 & Q2 Scopus journals, PubMed, and The Lancet Microbe, his work exemplifies cutting-edge innovation and scientific excellence.

Professional Development

Mohamed Imath is dedicated to advancing pharmaceutical research through nanotechnology, oncology, and phytochemistry. His eco-friendly synthesis of nanoparticles using plant extracts revolutionizes drug delivery and antimicrobial treatments. His expertise in AI-based recombinant vaccine development and gene apoptosis studies enhances cancer treatment. As the Founder of Healthmeds Generics, he ensures affordable generic medicines for all. At Kairos Kinetic, he promotes science communication through Thursday webinars, earning the Science Popularisation Award 2024 . His focus on public health awareness and scientific innovation makes him a leader in community-driven healthcare advancements.

Research Focus

Mohamed Imath’s research integrates pharmacology, nanotechnology, and molecular biology to develop next-generation therapeutics. He specializes in eco-friendly metal oxide nanoparticle synthesis (Ag, ZnO, TiO₂, Au, Fe₂O₃), targeting oral and human pathogens . His work in oncology focuses on anticancer activity and gene apoptosis studies for precision medicine . He is actively involved in AI-driven recombinant vaccine development and drug discovery for infectious diseases. His data analysis skills (SPSS, Prism) empower pharmaceutical research, while his contributions to phytochemicals enhance natural drug formulations. His innovative research is shaping the future of personalized medicine.

Awards And Honours

Science Popularisation Award 2024 – AVRS Society
10+ Articles Published – Scopus Q1 & Q2 Indexed Journals
2 Articles Published – PubMed Indexed Journals
Correspondence Article in Lancet Microbe (Impact Factor: 20.9)
UK Design Patent – “Modified High-Efficiency Membrane Extruder Equipment for Liposome Synthesis” (6344485)

Publication Top Noted

1️⃣ Eco-friendly synthesis of ZnO nanoparticles fabricated using Fioria vitifolia L. and their biomedical potentials – Microbial Pathogenesis, 2025,

2️⃣ Eco-friendly synthesis of betanin-conjugated zinc oxide nanoparticles: antimicrobial efficacy and apoptotic pathway activation in oral cancer cells – Molecular Biology Reports, 2024, Cited by: 2

3️⃣ Comment on, “Prospective analysis of STRATAFIX™ symmetric PDS plus suture for fascial closure in spinal surgery: a pilot study” – Neurosurgical Review, 2024,

4️⃣ Letter to editor: “Neuralink’s brain implant: a vision for enhanced human-machine integration” – Neurosurgical Review, 2024,

5️⃣ Fioria vitifolia-mediated silver nanoparticles: Eco-friendly synthesis and biomedical potential – Journal of Water Process Engineering, 2024, Cited by: 4

6️⃣ Early detection and rapid diagnosis of circulating HPV-DNA detected using droplet digital PCR – Oral Oncology Reports, 2024,

7️⃣ Using proton therapy to treat head and neck cancer and oral squamous cell carcinoma – Oral Oncology Reports, 2024,